13C20,15N10-Cyclic di-GMP (sodium salt)
(Synonyms: 13C20,15N10-c-di-GMP, 13C20,15N10-Cyclic diguanylate, 13C20,15N10-3’,5’-Cyclic diguanylic Acid) 目录号 : GC49912An internal standard for the quantification of cyclic di-GMP
Sample solution is provided at 25 µL, 10mM.
13C20,15N10-Cyclic di-GMP is intended for use as an internal standard for the quantification of cyclic di-GMP by GC- or LC-MS. Cyclic di-GMP is a second messenger in bacteria involved in diverse prokaryotic processes, including biofilm formation, motility, virulence, and cell cycling.1,2 In eukaryotic cells, cyclic di-GMP is detected by and binds to the transmembrane protein stimulator of interferon genes (STING; Kd = 1.21 µM), leading to activation of the innate immune system.3,4 It has been used at a preset molar ratio with STING dimers in binding assays to determine the binding constants of particularly tight binding partners, such as 2’3’-cGAMP. Cyclic di-GMP induces IFN-β mRNA expression in vitro (EC50 = 537.8 nM) but less potently than 2’3’-cGAMP , 3’2’-cGAMP, 3’3’-cGAMP , and 2’2’-cGAMP .
1.RÖmling, U., Galperin, M.Y., and Gomelsky, M.Cyclic di-GMP: The first 25 years of a universal bacterial second messengerMicrobiol. Mol. Biol. Rev.77(1)1-52(2013) 2.MartÍnez, L.C., and Vadyvaloo, V.Mechanisms of post-transcriptional gene regulation in bacterial biofilmsFront. Cell. Neurosci.4(38)1-15(2014) 3.Schaap, P.Cyclic di-nucleotide signaling enters the eukaryote domainIUBMB Life65(11)897-903(2013) 4.Zhang, X., Shi, H., Wu, J., et al.Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STINGMol. Cell51(2)226-235(2015)
Cas No. | SDF | Download SDF | |
别名 | 13C20,15N10-c-di-GMP, 13C20,15N10-Cyclic diguanylate, 13C20,15N10-3’,5’-Cyclic diguanylic Acid | ||
Canonical SMILES | O=[13C]1[15NH][13C]([15NH2])=[15N][13C]2=[13C]1[15N]=[13CH][15N]2[13C@@H]([13C@@H]3O)O[13C@@]([H])([13C@]3(OP([O-])(O[13CH2][13C@]([H])([13C@]4(O5)[H])O[13C@H]([13C@@H]4O)[15N]6[13C]([15N]=[13C]([15NH]7)[15NH2])=[13C]([15N]=[13CH]6)[13C]7=O)=O)[H])[13CH2]OP5([O-])=O.[Na+].[Na+] | ||
分子式 | [13C]20H22[15N]10O14P2 • 2Na | 分子量 | 764.2 |
溶解度 | Water: soluble | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.3086 mL | 6.5428 mL | 13.0856 mL |
5 mM | 0.2617 mL | 1.3086 mL | 2.6171 mL |
10 mM | 0.1309 mL | 0.6543 mL | 1.3086 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet